Induction of vesicular steatosis by amiodarone and tetracycline is associated with up‐regulation of lipogenic genes in heparg cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.24290PMID 21391224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.

  2010influential reference
• Increased Lipolysis in Adipose Tissues is Associated with Elevation of Systemic Free Fatty Acids and Insulin Resistance in Perilipin Null Mice

  2010cited by this paper
• Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.

  2009cited by this paper
• In vitro assay for drug‐induced hepatosteatosis using rat primary hepatocytes, a fluorescent lipid analog and gene expression analysis

  2009cited by this paper
• Running title page Running title : Functional stability of CYP P 450 enzymes in HepaRG cells

  2009cited by this paper
• Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

  2009cited by this paper
• Cytometric analysis for drug-induced steatosis in HepG2 cells.

  2009cited by this paper
• A novel pregnane X receptor and S14‐mediated lipogenic pathway in human hepatocyte

  2009cited by this paper
• Liver lipid metabolism.

  2008cited by this paper
• Evolving concepts in liver tissue modeling and implications for in vitro toxicology

  2008cited by this paper
• Gene expression in human NAFLD.

  2008cited by this paper
• Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor

  2007cited by this paper
• Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes

  2007cited by this paper
• Effects of steatosis on drug-metabolizing capability of primary human hepatocytes.

  2007cited by this paper
• Acute hepatotoxicity: a predictive model based on focused illumina microarrays.

  2007cited by this paper
• Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects

  2007cited by this paper
• Roles of phosphatidate phosphatase enzymes in lipid metabolism.

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS

  2006cited by this paper
• Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.

  2006cited by this paper
• Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet.

  2006cited by this paper
• Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.

  2006cited by this paper
• Genomic cluster and network analysis for predictive screening for hepatotoxicity.

  2006cited by this paper
• Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients.

  2006cited by this paper
• A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.

  2004influential reference
• Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential.

  2004cited by this paper
• Infection of a human hepatoma cell line by hepatitis B virus

  2002cited by this paper
• Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

  2001cited by this paper
• Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.

  2000cited by this paper
• Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

  1998cited by this paper
• Cationic Amphiphilic Drug-Induced Phospholipidosis

  1997cited by this paper
• Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein.

  1997cited by this paper
• Cell-generated nitric oxide inactivates rat hepatocyte mitochondria in vitro but reacts with hemoglobin in vivo.

  1996cited by this paper
• Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.

  1995cited by this paper
• Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases.

  1994cited by this paper
• Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.

  1993cited by this paper
• Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.

  1993cited by this paper
• Non‐alcoholic steatohepatitis: Impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis

  1991cited by this paper
• Histopathologic analysis of suspected amiodarone hepatotoxicity.

  1990cited by this paper
• Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.

  1990cited by this paper
• Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic

  1988cited by this paper
• Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues.

  1987cited by this paper
• Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.

  1984cited by this paper
• Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.

  1984cited by this paper
• Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.

  1975cited by this paper
• [Phospholipidosis caused by diethylaminoethoxyhexestrol].

  1971cited by this paper
• TETRACYCLINE TOXICITY IN PREGNANCY. LIVER AND PANCREATIC DYSFUNCTION.

  1964cited by this paper
• Evolving Concepts in Liver Tissue Modeling and Implications for in Vitro Toxicology 1. Introduction

  year unknowncited by this paper

• Modeling fatty liver disease and progression with stem cell derived hepatocytes

  2026cites this paper
• New approach methodologies for metabolic disruption: a high-throughput human liver cell phospholipidosis assay.

  2025cites this paper
• Physicochemical strategies for antibiotic removal in aquaculture wastewater: Mechanistic insights, technological challenges, and sustainable development pathways

  2025cites this paper
• Underlying mechanisms of PPCPs on sleep disorders in the elderly: An integrated epidemiology and network toxicology study

  2025cites this paper
• Mass spectrometric analysis of the amiodarone-induced alteration of phosphatidylcholines in living single cells.

  2025cites this paper
• A mechanistically-anchored and human stem cell-based in vitro test battery for assessing liver steatogenic potential of chemicals.

  2025cites this paper
• Distribution of amiodarone between lipid nanocapsules and residual micelles: Tangential flow filtration as a purification method and its impact on cytotoxicity.

  2025cites this paper
• Mitochondrial dysfunction in drug-induced hepatic steatosis: recent findings and current concept.

  2025cites this paper
• Transcriptomic and Proteomics Analysis of a Lipid-Loaded HepaRG Model for Steatosis Reveals Altered Regulation in Lipid and Xenobiotic Metabolism.

  2025cites this paper
• NAFLD’s possible link to exposure to environmental contaminants and overnutrition

  2025cites this paper
• Mechanism-based new approach methodologies for in vitro detection of chemical-induced liver steatosis.

  2025cites this paper
• A new alternative method using cyp3a65 expression in transgenic zebrafish embryos to assess metabolic endocrine-disrupting chemicals in the intestine.

  2025cites this paper
• A strategy to detect metabolic changes induced by exposure to chemicals from large sets of condition-specific metabolic models computed with enumeration techniques

  2024cites this paper
• Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

  2024cites this paper
• Livogrit prevents Amiodarone-induced toxicity in experimental model of human liver (HepG2) cells and Caenorhabditis elegans by regulating redox homeostasis

  2024influential citation
• Chlordecone-induced hepatotoxicity and fibrosis are mediated by the proteasomal degradation of septins.

  2024cites this paper
• Review article: Hepatic steatosis and its associations with acute and chronic liver diseases

  2024cites this paper
• Study of Electrospun Membranes Composed of PCL and Tilapia-Skin Collagen with Tetracycline or Chloramphenicol in Contact with Human Skin Fibroblasts for Wound Dressing Treatment

  2024cites this paper
• Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use

  2024cites this paper
• Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease

  2023cites this paper
• Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug‐induced liver injury

  2023cites this paper
• In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity

  2023cites this paper
• Adverse outcome pathway-based analysis of liver steatosis in vitro using human liver cell lines

  2023cites this paper
• Quantitative chemometric phenotyping of three-dimensional liver organoids by Raman spectral imaging

  2023cites this paper
• The heparan sulfate mimetic Muparfostat aggravates steatohepatitis in obese mice due to its binding affinity to lipoprotein lipase

  2023cites this paper
• AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease.

  2023cites this paper
• Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis

  2023cites this paper
• Integrating distribution kinetics and toxicodynamics to assess repeat dose neurotoxicity in vitro using human BrainSpheres: a case study on amiodarone

  2023cites this paper
• Hepatoprotective Effects of Nigella sativa essential oil against Acrylamide-induced Oxidative Stress and Inflammatory Cytokine Changes in Wistar Albino Rats

  2022cites this paper
• Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update

  2022cites this paper
• Oxidative-stress and long-term hepatotoxicity: comparative study in Upcyte human hepatocytes and hepaRG cells

  2022cites this paper
• Lipidomics profiles in hepatocytes from nonalcoholic steatohepatitis patients differ markedly from in vitro‐induced steatotic hepatocytes

  2022cites this paper
• In Vitro Models for Studying Chronic Drug-Induced Liver Injury

  2022influential citation
• Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis

  2022cites this paper
• Chemical screening of food-related chemicals for human fatty liver risk: Combining high content imaging of cellular responses with in vitro to in vivo extrapolation

  2022cites this paper
• In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation

  2022cites this paper
• Associations of acrylamide with non-alcoholic fatty liver disease in American adults: a nationwide cross-sectional study

  2021cites this paper
• Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction

  2021cites this paper
• A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease

  2021cites this paper
• Drug-induced Fatty Liver Disease: Pathogenesis and Treatment

  2021cites this paper
• HepaRG Maturation in Silk Fibroin Scaffolds: Toward Developing a 3D In Vitro Liver Model.

  2021cites this paper
• Analytical and Omics-based Advances in the Study of Drug-Induced Liver Injury.

  2021cites this paper
• Efficient Generation of Functional Hepatocytes from Human Induced Pluripotent Stem Cells for Disease Modeling and Disease Gene Discovery.

  2021cites this paper
• DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies

  2021cites this paper
• Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach

  2021cites this paper
• Assessing hepatoprotective effects of antioxidants on amiodarone-induced cytotoxicity in human hepatoma HepaRG cell line

  2021cites this paper
• Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models

  2021cites this paper
• 3,4-Dichloroaniline promotes fatty liver in zebrafish larvae

  2020cites this paper
• The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds

  2020cites this paper
• Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells.

  2020cites this paper
• Predicting direct hepatocyte toxicity in humans by combining high-throughput imaging of HepaRG cells and machine learning-based phenotypic profiling

  2020cites this paper
• Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity

  2020influential citation
• Autophagy alleviates amiodarone-induced hepatotoxicity

  2020cites this paper
• Transcript and protein marker patterns for the identification of steatotic compounds in human HepaRG cells.

  2020cites this paper
• An in vitro model of hepatic steatosis using lipid loaded induced pluripotent stem cell derived hepatocyte like cells

  2020cites this paper
• Antibiotics and Food Safety in Aquaculture.

  2020cites this paper
• Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice

  2020cites this paper
• Inhibition of oxygen-sensing prolyl hydroxylases increases lipid accumulation in human primary tubular epithelial cells without inducing ER stress

  2020cites this paper
• Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

  2019cites this paper
• AN OMICS BASED APPROACH FOR THE IDENTIFICATION OF BIOMARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE USING IN VITRO MODELS OF HEPATIC STEATOSIS

  2019cites this paper
• Structure-activity relationship study: Mechanism of cyto-genotoxicity of Nitropyrazole-derived high energy density materials family.

  2019cites this paper
• Mitochondrial Dysfunction Induced by Xenobiotics: Involvement in Steatosis and Steatohepatitis

  2019cites this paper
• EASL Clinical Practice Guidelines: Drug-induced liver injury

  2019cites this paper
• A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices

  2019cites this paper
• Frequent Modulation of the Sterol Regulatory Element Binding Protein (SREBP) by Chemical Exposure in the Livers of Rats.

  2019cites this paper
• Calcium Signaling As a Therapeutic Target for Liver Steatosis.

  2019cites this paper
• Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells

  2019cites this paper
• Human in vitro models of nonalcoholic fatty liver disease

  2019cites this paper
• EASL Clinical Practice Guidelines: Drug-induced liver injury.

  2019cites this paper
• Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization

  2018cites this paper
• Benzbromarone aggravates hepatic steatosis in obese individuals.

  2018cites this paper
• Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells

  2018influential citation
• Regulation of Drug Metabolism by the Interplay of Inflammatory Signaling, Steatosis, and Xeno-Sensing Receptors in HepaRG Cells

  2018cites this paper
• Human‐based systems: Mechanistic NASH modelling just around the corner?

  2018cites this paper
• Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole.

  2018cites this paper
• Role of xenobiotics in the induction and progression of fatty liver disease.

  2018cites this paper
• Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure

  2018cites this paper
• Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity

  2018cites this paper
• Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes

  2018cites this paper
• In Vitro Assessment of Mitochondrial Toxicity to Predict Drug-Induced Liver Injury

  2018cites this paper
• HepaRG Cells as a Model for Hepatotoxicity Studies

  2018cites this paper
• Mitochondrial Dysfunction in Drug‐Induced Liver Injury

  2018cites this paper
• Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone.

  2018cites this paper
• Drug-Induced Liver Toxicity

  2018influential citation
• Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity

  2017influential citation
• Towards the assessment of human-relevant repeated dose toxicity using an in vitro systems toxicological approach

  2017cites this paper
• Optimisation of in vitro sample preparation for LC-MS metabolomics applications on HepaRG cell cultures

  2017cites this paper
• An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D

  2017cites this paper
• Chronic and low exposure to a pharmaceutical cocktail induces mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean and obese mice

  2017cites this paper
• Editor’s Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis

  2017influential citation
• A Multi‐Parametric Fluorescent Assay for the Screening and Mechanistic Study of Drug‐Induced Steatosis in Liver Cells in Culture

  2017cites this paper
• A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis.

  2017cites this paper
• Transcriptional, functional and mechanistic comparisons of stem cell-derived hepatocytes, HepaRG cells and 3D human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury

  2017cites this paper
• Application of veterinary antibiotics in China’s aquaculture industry and their potential human health risks

  2017cites this paper
• Hepatic Amiodarone Lipotoxicity Is Ameliorated by Genetic and Pharmacological Inhibition of Endoplasmatic Reticulum Stress

  2017cites this paper
• The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy

  2017cites this paper
• Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury

  2017cites this paper
• Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.

  2017cites this paper
• HepaRG cells and 3 D human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury

  2017cites this paper
• A lipidomic cell‐based assay for studying drug‐induced phospholipidosis and steatosis

  2017cites this paper